STR Biotechnologies is a research-driven biotechnology manufacturer dedicated to developing innovative technologies for regenerative medicine, biotechnology, and medical device production. Through its scientific approach, advanced engineering capabilities, and commitment to quality, the company has established itself as a trusted partner in both domestic and international markets.

​

Since its foundation, STR Biotechnologies has closely followed global scientific advancements and emerging technologies in regenerative medicine. The company specializes in the development, manufacturing, and worldwide distribution of PRP, PRF, CGF, SVF, stem cell processing systems, exosome technologies, orthobiologic solutions, laboratory equipment, and advanced medical devices.

​

More than just a manufacturer, STR Biotechnologies is a technology-driven organization that creates value for healthcare professionals, clinics, distributors, and healthcare brands worldwide. By placing quality, sustainability, scientific integrity, and patient safety at the center of every process, the company delivers high-value solutions tailored to the evolving needs of modern healthcare.

​

Located in the Çorum Organized Industrial Zone, STR Biotechnologies operates from a modern manufacturing facility built on a total area of 6,200 m², including 2,100 m² of enclosed production space. The facility incorporates clean room infrastructure, plastic injection technologies, CNC machining capabilities, advanced quality control systems, and modern production processes designed to meet international standards.

​

Innovation and research form the foundation of STR Biotechnologies' corporate culture. Through continuous investment in research and development, the company is committed to advancing next-generation regenerative medicine technologies and creating innovative solutions that shape the future of healthcare.

​

Today, STR Biotechnologies operates in the following areas:

• PRP Kit and Tube Systems
• PRF and i-PRF Technologies
• CGF Technologies
• SVF and Cellular Processing Systems
• Bone Marrow Concentration Systems (BMAC)
• Platelet-Derived Exosome Technologies
• Cytokine and Interleukin Therapy Systems
• Orthobiologic and Regenerative Treatment Solutions
• Centrifuge and Laboratory Technologies
• Major Ozone Therapy Systems
• Intra-Articular Collagen and Polynucleotide Technologies
• OEM and Private Label Medical Manufacturing Solutions

​

STR Biotechnologies considers contributing to scientific advancement an essential part of its corporate responsibility. Through physician training programs, hands-on workshops, scientific events, and academic collaborations, the company actively supports the growth and development of the regenerative medicine ecosystem.

​

Guided by international quality standards, sustainable manufacturing principles, and a forward-looking vision, STR Biotechnologies is committed to developing the biotechnology and regenerative medicine solutions of tomorrow.

Today and in the future, STR Biotechnologies will continue to create value, drive innovation, and support global healthcare markets through reliable, advanced, and high-quality biotechnology solutions.